Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The anomalous pharmacology of fentanyl
Eamonn Kelly, Katy J. Sutcliffe, Damiana Cavallo, et al.
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 797-812
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Molecular recognition of morphine and fentanyl by the human μ-opioid receptor
Youwen Zhuang, Yue Wang, Bingqing He, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4361-4375.e19
Open Access | Times Cited: 155
Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis
Eduardo R. Butelman, Yuefeng Huang, David H. Epstein, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 11, pp. 1639-1647
Open Access | Times Cited: 44
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Teijo I. Saari, John Strang, Ola Dale
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 4, pp. 397-422
Open Access | Times Cited: 16
Treatment of overdose in the synthetic opioid era
Phil Skolnick
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108019-108019
Open Access | Times Cited: 85
Biased Agonism: Lessons from Studies of Opioid Receptor Agonists
Eamonn Kelly, Alexandra E. Conibear, Graeme Henderson
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 491-515
Open Access | Times Cited: 48
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl
H. Elizabeth Bird, Andrew S. Huhn, Kelly E. Dunn
Journal of Addiction Medicine (2023) Vol. 17, Iss. 5, pp. 503-508
Closed Access | Times Cited: 36
Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone
Mark J. Ellison, Emily Hutton, Lynn R. Webster, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 7, pp. 828-839
Open Access | Times Cited: 9
Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use
Edward V. Nunes, Sandra D. Comer, Michelle R. Lofwall, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2417377-e2417377
Open Access | Times Cited: 9
Fentanyl-induced Brugada phenocopy: A case report
Serhat Kesriklioğlu, Şükrü Gür, Ahmet Taha Şahin, et al.
Journal of Electrocardiology (2025) Vol. 90, pp. 153922-153922
Closed Access | Times Cited: 1
A Neuropharmacological Model to Explain Buprenorphine Induction Challenges
Mark K. Greenwald, Andrew A. Herring, Jeanmarie Perrone, et al.
Annals of Emergency Medicine (2022) Vol. 80, Iss. 6, pp. 509-524
Closed Access | Times Cited: 37
Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy
Yuqiao Liu, Junmin Li, Shenghao Xiao, et al.
Biosensors (2023) Vol. 13, Iss. 7, pp. 726-726
Open Access | Times Cited: 22
IUPHAR themed review: Opioid efficacy, bias, and selectivity
Nokomis Ramos‐Gonzalez, Barnali Paul, Susruta Majumdar
Pharmacological Research (2023) Vol. 197, pp. 106961-106961
Open Access | Times Cited: 18
Systematic review on intentional non-medical fentanyl use among people who use drugs
Vivian W. L. Tsang, James S.H. Wong, Jean N. Westenberg, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 8
Investigation of monoclonal antibody CSX-1004 for fentanyl overdose
Paul T. Bremer, Emily L. Burke, Andrew C. Barrett, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Carfentanil is a β‐arrestin‐biased agonist at the μ opioid receptor
Nokomis Ramos‐Gonzalez, Sam Groom, Katy J. Sutcliffe, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 18, pp. 2341-2360
Open Access | Times Cited: 15
Pharmacokinetic Properties of an FDA‐approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose
Roger Crystal, Mark J. Ellison, Charlotte Purdon, et al.
Clinical Pharmacology in Drug Development (2023) Vol. 13, Iss. 1, pp. 58-69
Open Access | Times Cited: 15
Focus on fentanyl in females: Sex and gender differences in the physiological and behavioral effects of fentanyl
K. Little, Therese A. Kosten
Frontiers in Neuroendocrinology (2023) Vol. 71, pp. 101096-101096
Open Access | Times Cited: 15
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice
Kara M. Rademeyer, Sara R. Nass, Austin M. Jones, et al.
Journal of NeuroVirology (2024) Vol. 30, Iss. 1, pp. 1-21
Open Access | Times Cited: 5
Comparison of theμ-Opioid Receptor Antagonists Methocinnamox and Naloxone to Reverse and Prevent the Ventilatory Depressant Effects of Fentanyl, Carfentanil, 3-Methylfentanyl, and Heroin in Male Rats
Takato Hiranita, Nicholas P. Ho, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 1, pp. 4-17
Open Access | Times Cited: 5
Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest
Céline M. Laffont, Prasad Purohit, Nash Delcamp, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Interaction With the Lipid Membrane Influences Fentanyl Pharmacology
Katy J. Sutcliffe, Robin A. Corey, Norah Alhosan, et al.
Advances in Drug and Alcohol Research (2022) Vol. 2
Open Access | Times Cited: 21
Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing
Santhosh M. Baby, Walter J. May, Paulina M. Getsy, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention
Lakshit Jain, Jasleen Kaur, Shahana Ayub, et al.
World Journal of Psychiatry (2024) Vol. 14, Iss. 6, pp. 760-766
Open Access | Times Cited: 4
Identification of 5-aminometonitazene and 5-acetamidometonitazene in a postmortem case: are nitro-nitazenes unstable?
Claire Parks, Peter Maskell, Denise A. McKeown, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 9, pp. 691-700
Closed Access | Times Cited: 4
The Rise of Fentanyl: Molecular Aspects and Forensic Investigations
C Barletta, Vincenzo Natale, Massimiliano Esposito, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 444-444
Open Access
Page 1 - Next Page

Scroll to top